Cargando…

Inflammatory Immune Responses and Gut Microbiota Changes Following Campylobacter coli Infection of IL-10(-/-) Mice with Chronic Colitis

Human infections with the food-borne enteropathogens Campylobacter are progressively rising. Recent evidence revealed that pre-existing intestinal inflammation facilitates enteropathogenic infection subsequently exacerbating the underlying disease. Given that only little is known about C. coli–host...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heimesaat, Markus M., Genger, Claudia, Biesemeier, Nina, Klove, Sigri, Weschka, Dennis, Mousavi, Soraya, Bereswill, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400060/ https://www.ncbi.nlm.nih.gov/pubmed/32664563 http://dx.doi.org/10.3390/pathogens9070560

Ejemplares similares

Toll-Like Receptor-4 Dependent Intestinal and Systemic Sequelae Following Peroral Campylobacter coli Infection of IL10 Deficient Mice Harboring a Human Gut Microbiota
por: Kløve, Sigri, et al.
Publicado: (2020)

Toll-Like Receptor-4 Is Involved in Mediating Intestinal and Extra-Intestinal Inflammation in Campylobacter coli-Infected Secondary Abiotic IL-10(−/−) Mice
por: Kløve, Sigri, et al.
Publicado: (2020)

The Host-Specific Intestinal Microbiota Composition Impacts Campylobacter coli Infection in a Clinical Mouse Model of Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Microbiota composition and inflammatory immune responses upon peroral application of the commercial competitive exclusion product Aviguard(®) to microbiota-depleted wildtype mice
por: HEIMESAAT, MARKUS M., et al.
Publicado: (2020)

The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection
por: GENGER, CLAUDIA, et al.
Publicado: (2020)

Survey of Pathogen-Lowering and Immuno-Modulatory Effects Upon Treatment of Campylobacter coli-Infected Secondary Abiotic IL-10(−/−) Mice with the Probiotic Formulation Aviguard(®)
por: Weschka, Dennis, et al.
Publicado: (2021)

Immune-modulatory Properties of the Octapeptide NAP in Campylobacter jejuni Infected Mice Suffering from Acute Enterocolitis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Pituitary Adenylate Cyclase-Activating Polypeptide Alleviates Intestinal, Extra-Intestinal and Systemic Inflammatory Responses during Acute Campylobacter jejuni-induced Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10(−/−) Mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Treatment with the Probiotic Product Aviguard(®) Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Human microbiota associated IL-10(−/−) mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota
por: Shayya, Nizar W., et al.
Publicado: (2023)

Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine Campylobacter jejuni Infection Model
por: Bereswill, Stefan, et al.
Publicado: (2022)

Campylobacter jejuni infection induces acute enterocolitis in IL-10(-/-) mice pretreated with ampicillin plus sulbactam
por: Heimesaat, Markus M., et al.
Publicado: (2022)

Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis
por: Bereswill, Stefan, et al.
Publicado: (2021)

Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2021)

Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis—Results from a Preclinical Placebo-Controlled Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Disease alleviating effects following prophylactic lemon and coriander essential oil treatment in mice with acute campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2023)

Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2023)

Campylobacter concisus Impairs Sodium Absorption in Colonic Epithelium via ENaC Dysfunction and Claudin-8 Disruption
por: Nattramilarasu, Praveen Kumar, et al.
Publicado: (2020)

Peroral Clove Essential Oil Treatment Ameliorates Acute Campylobacteriosis—Results from a Preclinical Murine Intervention Study
por: Bereswill, Stefan, et al.
Publicado: (2021)

Protease Activity of Campylobacter jejuni HtrA Modulates Distinct Intestinal and Systemic Immune Responses in Infected Secondary Abiotic IL-10 Deficient Mice
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2020)

Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in Campylobacter jejuni Infected Mice Harboring a Human Gut Microbiota
por: Heimesaat, Markus M., et al.
Publicado: (2019)

Microbiota Composition and Immune Responses During Campylobacter Jejuni Infection in Conventionally Colonized IL-10(–/–) Mice Lacking Nucleotide Oligomerization Domain 2
por: Heimesaat, Markus M., et al.
Publicado: (2016)

Therapeutic Oral Application of Carvacrol Alleviates Acute Campylobacteriosis in Mice Harboring a Human Gut Microbiota
por: Foote, Minnja S., et al.
Publicado: (2023)

Vitamin C alleviates acute enterocolitis in Campylobacter jejuni infected mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni
por: Lobo de Sá, Fábia D., et al.
Publicado: (2021)

The IL-23/IL-22/IL-18 axis in murine Campylobacter jejuni infection
por: Heimesaat, Markus M., et al.
Publicado: (2016)

Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice
por: Du, Ke, et al.
Publicado: (2022)

The Role of IL-23, IL-22, and IL-18 in Campylobacter Jejuni Infection of Conventional Infant Mice
por: Heimesaat, Markus M., et al.
Publicado: (2016)

Absence of Nucleotide-Oligomerization-Domain-2 Is Associated with Less Distinct Disease in Campylobacter jejuni Infected Secondary Abiotic IL-10 Deficient Mice
por: Heimesaat, Markus M., et al.
Publicado: (2017)

Small Intestinal Pro-Inflammatory Immune Responses Following Campylobacter Jejuni Infection of Secondary Abiotic IL-10(–/–) Mice Lacking Nucleotide-Oligomerization-Domain-2
por: Heimesaat, Markus M., et al.
Publicado: (2017)

Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Vitamin D in Acute Campylobacteriosis–Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model
por: Mousavi, Soraya, et al.
Publicado: (2019)

Molecular Targets in Campylobacter Infections
por: Heimesaat, Markus M., et al.
Publicado: (2023)

Intestinal Microbiota Shifts towards Elevated Commensal Escherichia coli Loads Abrogate Colonization Resistance against Campylobacter jejuni in Mice
por: Haag, Lea-Maxie, et al.
Publicado: (2012)

Murine fecal microbiota transplantation lowers gastrointestinal pathogen loads and dampens pro-inflammatory immune responses in Campylobacter jejuni infected secondary abiotic mice
por: Heimesaat, Markus M., et al.
Publicado: (2019)

Campylobacter jejuni Induces Acute Enterocolitis in Gnotobiotic IL-10(−/−) Mice via Toll-Like-Receptor-2 and -4 Signaling
por: Haag, Lea-Maxie, et al.
Publicado: (2012)

Galanin receptor 3 attenuates inflammation and influences the gut microbiota in an experimental murine colitis model
por: Brunner, Susanne M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vbtnk60r3vqnp9g3mm1dtad7jr